
Global Dengue Vaccines Competitive Landscape Professional Research Report 2025
Description
Global Dengue Vaccines Competitive Landscape Professional Research Report 2025
Research Summary
Dengue vaccines are immunizations developed to protect against dengue fever, a viral disease transmitted through the bites of infected mosquitoes, primarily Aedes aegypti and Aedes albopictus. The vaccines are designed to stimulate the immune system to produce antibodies against the dengue virus, preventing or reducing the severity of the infection if a vaccinated person is exposed to the virus. Several dengue vaccines have been developed, including the CYD-TDV vaccine (Dengvaxia), which has been approved for use in some countries. Dengue vaccines are particularly important in regions where dengue is endemic and poses a significant public health threat. However, developing an effective dengue vaccine has been challenging due to the existence of multiple dengue virus serotypes, which require the vaccine to provide protection against all four serotypes. Continued research and efforts are focused on improving dengue vaccines to enhance their safety and efficacy, contributing to global efforts to control and prevent the spread of dengue fever.
According to DIResearch's in-depth investigation and research, the global Dengue Vaccines market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Dengue Vaccines include Sanofi, Takeda etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Dengue Vaccines. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Dengue Vaccines market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Dengue Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Dengue Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Dengue Vaccines Include:
Sanofi
Takeda
Dengue Vaccines Product Segment Include:
Dengvaxia
TAK-003
Others
Dengue Vaccines Product Application Include:
Preventive Vaccination in Endemic Regions
Protection for Travelers
Integration into Routine Immunization Programs
Occupational Vaccination
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Dengue Vaccines Industry PESTEL Analysis
Chapter 3: Global Dengue Vaccines Industry Porter’s Five Forces Analysis
Chapter 4: Global Dengue Vaccines Major Regional Market Size and Forecast Analysis
Chapter 5: Global Dengue Vaccines Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Dengue Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Dengue Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Dengue Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Dengue Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Dengue Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Dengue Vaccines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Dengue Vaccines Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Dengue Vaccines Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Dengue Vaccines Product by Type
- 1.2.1 Dengvaxia
- 1.2.2 TAK-003
- 1.2.3 Others
- 1.3 Dengue Vaccines Product by Application
- 1.3.1 Preventive Vaccination in Endemic Regions
- 1.3.2 Protection for Travelers
- 1.3.3 Integration into Routine Immunization Programs
- 1.3.4 Occupational Vaccination
- 1.4 Global Dengue Vaccines Market Size Analysis (2020-2032)
- 1.5 Dengue Vaccines Market Development Status and Trends
- 1.5.1 Dengue Vaccines Industry Development Status Analysis
- 1.5.2 Dengue Vaccines Industry Development Trends Analysis
- 2 Dengue Vaccines Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Dengue Vaccines Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Dengue Vaccines Market Analysis by Regions
- 4.1 Dengue Vaccines Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Dengue Vaccines Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Dengue Vaccines Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Dengue Vaccines Revenue Forecast by Region (2026-2032)
- 5 Global Dengue Vaccines Market Size by Type and Application
- 5.1 Global Dengue Vaccines Market Size by Type (2020-2032)
- 5.2 Global Dengue Vaccines Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Dengue Vaccines Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Dengue Vaccines Market Size by Type
- 6.4 North America Dengue Vaccines Market Size by Application
- 6.5 North America Dengue Vaccines Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Dengue Vaccines Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Dengue Vaccines Market Size by Type
- 7.4 Europe Dengue Vaccines Market Size by Application
- 7.5 Europe Dengue Vaccines Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Dengue Vaccines Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Dengue Vaccines Market Size by Type
- 8.4 China Dengue Vaccines Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Dengue Vaccines Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Dengue Vaccines Market Size by Type
- 9.4 APAC (excl. China) Dengue Vaccines Market Size by Application
- 9.5 APAC (excl. China) Dengue Vaccines Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Dengue Vaccines Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Dengue Vaccines Market Size by Type
- 10.4 Latin America Dengue Vaccines Market Size by Application
- 10.5 Latin America Dengue Vaccines Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Dengue Vaccines Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Dengue Vaccines Market Size by Type
- 11.4 Middle East & Africa Dengue Vaccines Market Size by Application
- 11.5 Middle East & Africa Dengue Vaccines Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Dengue Vaccines Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Dengue Vaccines Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Dengue Vaccines Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Sanofi
- 13.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Sanofi Dengue Vaccines Product Portfolio
- 13.1.3 Sanofi Dengue Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Takeda
- 13.2.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Takeda Dengue Vaccines Product Portfolio
- 13.2.3 Takeda Dengue Vaccines Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Dengue Vaccines Industry Chain Analysis
- 14.2 Dengue Vaccines Industry Raw Material and Suppliers Analysis
- 14.2.1 Dengue Vaccines Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Dengue Vaccines Typical Downstream Customers
- 14.4 Dengue Vaccines Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.